SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Phage (PTXX): Antibiotics to fight super-resistant bugs
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: Bhag Karamchandani who wrote ()7/6/1999 5:19:00 PM
From: JYatsu  Read Replies (1) of 23
 
As a surgeon, the problem with these superbugs as you call them is huge. They occur in hospitals where the antibiotics are used and regular bacteria are transformed into resistant ones. I'm unable to give you any ideas of the efficacy of Phage Therapeutics approach, but if efficacious there would be a huge market.The two most common resistant bacteria are MRSA and VRE, Methicillin resistant Staph aureus and Vancomycin resistant staph Epi. Every hospital would have to carry some in their pharmacy in order to treat any out breaks, etc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News